about
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPreexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbitsCo-dependence of HTLV-1 p12 and p8 functions in virus persistenceGlucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir.Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2',3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2,3-dioxygenase blockadeRegulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120.Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.Not just sheer luck! Immune correlates of protection against HIV-1 infection.Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaques.Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.Genetic and immune determinants of immune activation in HIV-exposed seronegative individuals and their role in protection against HIV infection.Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimenInhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by CytarabineSMYD3 promotes the epithelial-mesenchymal transition in breast cancer.Genetic and epigenetic regulation of natural resistance to HIV-1 infection: new approaches to unveil the HESN secretInterleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection
P50
Q30532861-347076E7-1ECE-41BA-B25C-AF07645AE2D2Q33676572-6AC10CFB-6D4F-4A2C-8EC9-69456FE5131AQ34310872-DBC980C8-0A20-4C6A-B3E1-E458A4944B3AQ34466396-517D0686-D159-4418-852B-7E453C8088B2Q34870353-72CD5FD0-EB86-436A-84DC-B960367C8962Q35261449-6F4C80CA-BD53-45E4-BEEA-82457E2F1F2BQ35666030-0CD205AF-A7BE-46F2-93D5-E9C1364F5090Q36075224-F9C66740-AFD2-44D4-9DC8-67DF4D89FC2CQ36667917-E65A5922-C901-471B-BC75-429713A6CBB8Q37052319-AE645393-36D9-4A29-92C0-E5374D1429EDQ37547587-513D4BC9-C2F2-4E19-9393-0E8AD1733B30Q37686199-B9F9C7E1-F9C0-43BC-9D1B-1EBF236CBA80Q47095769-3F2F9FDF-E9DC-4305-A8E9-30D8EB8B339CQ47563387-9093D9B5-5921-44F6-9851-3C30F1CCA6C4Q58167843-B9D3DE16-7F9E-470C-B6F7-26EDC1CB8E61Q59356083-66BC156D-37CD-4E56-B9E9-527F98279FA2Q64882163-4672ECBB-6342-4E4D-A0B5-07EB2FDA488CQ89835505-B1681E29-EDB4-4073-88DF-8E06E212886EQ90035712-1C35697C-9899-4113-B9EA-B1B12877C7FD
P50
description
researcher ORCID ID = 0000-0003-0735-8331
@en
name
Claudio Fenizia
@ast
Claudio Fenizia
@en
Claudio Fenizia
@es
Claudio Fenizia
@nl
type
label
Claudio Fenizia
@ast
Claudio Fenizia
@en
Claudio Fenizia
@es
Claudio Fenizia
@nl
prefLabel
Claudio Fenizia
@ast
Claudio Fenizia
@en
Claudio Fenizia
@es
Claudio Fenizia
@nl
P1153
23049982600
P21
P31
P496
0000-0003-0735-8331